Abstract:Tumor behavior, including its response to treatments, is influenced by interactions between mesenchymal and malignant cells, as well as their spatial arrangement. To study tumor biology and evaluate anticancer drugs, accurate 3D tumor models are essential. Here, we developed an in vitro biomimetic hepatoma microenvironment model by combining an extracellular matrix (3DM-7721). Initially, the internal grid structure, composed of 10/6 % GelMA/gelatin loaded with SMMC-7721 cells, was printed using 3D bioprinting. The external component consisted of fibroblasts and human umbilical vein endothelial cells loaded with 10/3 % GelMA/gelatin. A control model (3DP-7721) lacked external cell loading. GelMA/gelatin hydrogels provided robust structural support and biocompatibility. The SMMC-7721 cells in the 3DM-7721 model exhibit superior tumor-associated gene expression and proliferation characteristics when compared to the 3DP-7721 model. Furthermore, the 3DM-7721 type exhibited increased resistance to anticancer agents. SMMC-7721 cells in the 3DM-7721 model exhibit significant tumorigenicity in nude mice. The 3DM-7721 model group showed pathological characteristics of malignant tumors, with a high degree of deterioration, and a significant positive correlation between malignant tumor-related gene pathways. This high-fidelity 3DM-7721 tumor microenvironment model is invaluable for studying tumor progression, devising effective treatment strategies, and discovering drugs. Statement of significance 1. A hepatoma microenvironment model (3DM-7721) incorporating an extracellular matrix that is designed to establish solid tumor models in vitro . 2. This model contains a 3D-printed internal tumor component of liver cancer cells loaded with 10/6 % gelatin methacrylate (GelMA)/gelatin (the 3DP-7721 model) and an external extracellular-matrix component of fibroblasts and human umbilical vein endothelial cells loaded with 10/3 % GelMA/gelatin. 3. The 3DM-7721 model outperforms the 3DP-7721 model in terms of the SMMC-7721 cell proliferation characteristics and tumorigenicity, tumor-related gene expression, anticancer drug resistance, and malignant tumor characteristics.

3D Bioprinted Glioma Stem Cells for Brain Tumor Model and Applications of Drug Susceptibility.

3dbioprinted Glioma Microenvironment For Glioma Vascularization

Bioprinting of Glioma Stem Cells Improves Their Endotheliogenic Potential.

Biomimetic Three-Dimensional Glioma Model Printed in Vitro for the Studies of Glioma Cells and Neurons Interactions.

3D bioprinted glioma cell-laden scaffolds enriching glioma stem cells via epithelial-mesenchymal transition.

Comprehensive insight into 3D bioprinting technology for brain tumor modeling

Vascularization Ability of Glioma Stem Cells in Different Three-Dimensional Microenvironments.

Applications of 3D Bioprinting Technology to Brain Cells and Brain Tumor Models: Special Emphasis to Glioblastoma

3D Bioprinted Hyaluronic Acid-Based Cell-Laden Scaffold for Brain Microenvironment Simulation

3D Bioprinting of in Vitro Porous Hepatoma Models: Establishment, Evaluation, and Anticancer Drug Testing

3D Bioprinting of Tumor Models and Potential Applications

A 3D Bioprinted Human Neurovascular Unit Model of Glioblastoma Tumor Growth (Adv. Healthcare Mater. 15/2024)

In Vitro Glioblastoma Model on a Plate for Localized Drug Release Study from a 3D-Printed Drug-Eluted Hydrogel Mesh

Engineering a High-Throughput 3-D In Vitro Glioblastoma Model

A 3D bioprinted tumor model fabricated with gelatin/sodium alginate/decellularized extracellular matrix bioink

Bioprinting of Novel 3D Tumor Array Chip for Drug Screening

Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug Research.

Coaxially Bioprinted Cell-Laden Tubular-Like Structure for Studying Glioma Angiogenesis

Grafting of 3D Bioprinting to in Vitro Drug Screening: A Review

3D bioprinting of an in vitro hepatoma microenvironment model: Establishment, evaluation, and anticancer drug testing